A crossover intervention trial to evaluate the impact of rapid on-admission screening in preventing MRSA infection in surgery.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22295

Enrollment

20000

Registered

2007-08-27

Start date

2004-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MRSA control in surgery.

Interventions

Rapid MRSA screening.

Eligibility

Inclusion criteria

Inclusion criteria: All patients admitted to the surgical department for >24 hours.

Exclusion criteria

Exclusion criteria: Ambulatory surgery.

Design outcomes

Primary

Measure	Time frame
Number of patients with nosocomial MRSA infection acquired in surgery, expressed as incidence per 1000 patient-days	—

Secondary

Measure	Time frame
1. Nosocomial MRSA acquisition rate (expressed as the rate of new MRSA cases detected by any type of clinical isolate in previously MRSA-free patients per 1000 patient-days); 2. The rate of surgical site infections (per 100 procedures) and other site-specific infections caused by MRSA.	—

Contacts

Public ContactStephan Harbarth

Geneva University Hospitals Infection Control Program

stephan.harbarth@hcuge.ch+41 22 372 3357

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)